Latest news
×

newsinfo.inquirer.net Novavax reports promising early trial results of COVID-19 vaccine

US biotech company Novavax on Tuesday announced its experimental COVID-19 vaccine elicited a robust immune response, producing more antibodies than are present in recovered patients, and with
newsinfo.inquirer.net
 127